Loading...
Long-term efficacy of vildagliptin in patients with type 2 diabetes undergoing hemodialysis
BACKGROUND: There are few studies evaluating long-term glycemic control using a dipeptidyl peptidase-4 inhibitor in type 2 diabetes patients with end-stage renal disease (ESRD). The aim of this study was to evaluate the safety and efficacy of vildagliptin therapy over 2 years in type 2 diabetes with...
Na minha lista:
| Udgivet i: | J Diabetes Metab Disord |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4635589/ https://ncbi.nlm.nih.gov/pubmed/26550558 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40200-015-0214-6 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|